Honasa Consumer, the parent company of the Mamaearth beauty brand, reported a consolidated net profit of Rs 73.2 crore for the second quarter of the fiscal year 2026-27. This figure represents an 87% increase from the Rs 39.2 crore profit recorded in the same period a year earlier, according to financial statements accessed from the National Stock Exchange (NSE). Revenue from operations also expanded significantly, rising 36% to Rs 731.2 crore compared to Rs 538.1 crore in the previous year.
Despite the strong year-on-year performance, the company experienced a quarterly decline. Profit fell 19% from Rs 90.4 crore in the first quarter of FY27, and operating revenue slipped 3% from Rs 755.9 crore. Varun Alagh, co-founder and CEO, highlighted that the company delivered its highest growth since listing, with EBITDA nearly doubling to Rs 93 crore. He noted that focus categories, which now contribute more than 80% of the business, grew over 40% year-on-year. The contribution margin for these specific product lines increased by 369 basis points, according to a document excerpt from the company.
In a significant strategic shift, Honasa announced it had called off its planned acquisition of a 58% stake in Mumbai-based nutraceuticals brand Fluence Pharma. The board had initially approved the proposal in June, with plans to acquire the remaining stake over five to seven years. The company stated the deal was terminated due to the non-fulfilment of closing conditions specified in the Share Purchase Agreement. Instead, Honasa established a wholly owned subsidiary, Honasa Health Private Ltd, to operate its business-to-consumer nutraceuticals business, having invested Rs 10 lakh in the new entity as of July 7, 2026.
The company’s growth was driven by strong performance across multiple channels. Sales through e-commerce platforms such as Flipkart and Blinkit rose 20% year-on-year, while sales in general and modern trade increased by 40%. Products are now available across 3.2 lakh FMCG retail outlets in India. The flagship Mamaearth brand continued to record revenue growth in the high teens, while younger brands under the company’s strategy, including Aqualogica and Dr. Sheth’s, clocked a 45% sales growth. Total expenses rose 29% to Rs 652.4 crore, with advertising being the largest expense at Rs 245 crore.
